Medicenna Therapeutics Corp.
NASDAQ:MDNA
0.157 (USD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -10.048 | -22.577 | -17.289 | -8.277 | -4.708 | -7.465 | -7.631 | -1.334 | -0.001 | -0.001 |
| Depreciation & Amortization
| 0.004 | 0.038 | 0.04 | 0.008 | 0.007 | 0.01 | 0.006 | 0.001 | 0 | 0 |
| Deferred Income Tax
| -5.419 | 0 | 0.267 | 0.062 | 0.628 | 0.951 | 0.264 | 0 | 0 | 0 |
| Stock Based Compensation
| 1.371 | 1.415 | 1.006 | 1.125 | 0.999 | 1.617 | 0.14 | 0 | 0 | 0 |
| Change In Working Capital
| 2.41 | -1.844 | 0.68 | -0.793 | 0.684 | 0.451 | 0.752 | 0.103 | -0 | -0 |
| Accounts Receivables
| 0.001 | -0 | -0.002 | 0 | 0 | 0 | 0 | 0 | -0 | -0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | -1.452 | 0 | 0 | 0 | 0.452 | 0.782 | 0.314 | 0 | 0 |
| Other Working Capital
| 2.409 | -0.392 | 0.682 | -0.793 | 0.684 | -0 | -0.03 | -0.211 | 0 | 0 |
| Other Non Cash Items
| -0.975 | -0.616 | -0.015 | -1.079 | -5.646 | -5.688 | -0.573 | -1.341 | -0 | 0 |
| Operating Cash Flow
| -12.657 | -23.584 | -15.311 | -8.954 | -8.037 | -10.124 | -7.305 | -2.571 | -0.001 | -0.001 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | -0.005 | 0 | -0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -10 | -10 | -15 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 20.05 | 15.013 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0.01 | 0.005 | -0.015 | -0.354 | -0.14 | 0.609 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 10.05 | 5.013 | -15 | -0.354 | -0.14 | 0.603 | 0 | -0 | 0 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | -0.037 | -0.039 | -0.003 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 24.76 | 3.509 | 11.411 | 38.375 | 3.58 | 0 | 9.231 | 3.324 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.025 | 0.406 | 6.884 | 5.912 | 3.242 | 0 | 6.155 | 4.528 | 0.001 | 0 |
| Financing Cash Flow
| 24.76 | 3.878 | 18.256 | 44.284 | 6.822 | 0.469 | 15.386 | 7.852 | 0.001 | 0 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0.958 | -0.184 | -0.281 | -0.003 | 0.032 | -0.304 | 0.016 | -0.068 | -0 | 0 |
| Net Change In Cash
| 13.061 | -9.84 | 7.677 | 20.327 | -1.568 | -10.099 | 8.699 | 5.213 | 0 | -0 |
| Cash At End Of Period
| 33.596 | 20.535 | 30.375 | 22.698 | 2.371 | 3.939 | 14.038 | 5.339 | 0 | 0 |